-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

4094 T Lymphopenia and Aged Immune System Characterize Immunodeficiency in Adult Patients with Telomere Biology Disorders

Program: Oral and Poster Abstracts
Session: 509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III
Hematology Disease Topics & Pathways:
Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Genomics, Hematopoiesis, Diseases, Immune Disorders, Immunodeficiency, Immunology, Biological Processes, Molecular biology, Pathogenesis
Monday, December 9, 2024, 6:00 PM-8:00 PM

Luiz Fernando Bazzo Catto, MD1,2, Nidhi Aggarwal, BS3*, Ruba Shalhoub4*, Natthakan Thongon, PhD5, Tania Rene Machado, RN, BSN6*, Ivana Darden, RN7*, Jennifer Lotter, ms7, Bhavisha A. Patel, MD7, Geraldine Aubert, PhD8*, Colin O. Wu, PhD4*, Simona Colla, PhD9, Cynthia E. Dunbar, MD10, Fernanda Rodrigues, PhD11* and Emma M. Groarke, MD7

1Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
2Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Ribeirão Preto, Brazil
3Hematology Branch, National Heart, Lung and Blood Institute, Bethesda
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Office of Research Nurses, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
7Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
8British Columbia Cancer Agency, Vancouver, BC, CAN
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
10Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NHLBI/NIH, Bethesda, MD
11Hematology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda

Immunodeficiency in telomere biology disorders (TBDs) is often observed in patients with severe phenotypes presenting at a young age, as in dyskeratosis congenita. The immune system of adult TBD patients, including risk of infection and correlation with survival has not been well characterized.

We reviewed the clinical records of 88 TBD patients (median age [range] = 35 [5-76]; 93% with a known germline mutation) followed at NHLBI since 2002. Significant infections were defined as opportunistic, recurrent (two or more severe infections in one year, three or more respiratory infections in one year, or the need for antibiotics for two months per year), or infections that required hospitalization. Longitudinal data of blood counts and T, B, and NK (TBNK) cell immunophenotyping were available for 88 and 55 patients, respectively. Lymphopenia and neutropenia were defined as ≤ 1.2 cell/mL and 0.5 cell/mL. Immunodeficiency was defined by CD8 ≤ 178 cell/µL, CD4 ≤ 334 cells/µL, or CD19 ≤ 60 cells/µL.

In this adult cohort, 32/88 (36%) had a clinically significant infection history: 8/32 (25%) opportunistic, 16/32 (50%) recurrent, and 21/32 (65%) requiring hospitalization. Of 88 patients, 41 were lymphopenic and only 3 were neutropenic. Of 55 patients with available data for TBNK subsets, 29 were immunodeficient. Twenty-three had decreased CD3 counts, including 22 patients with decreased CD4 count and 13 patients with decreased CD8 count. B lymphopenia was observed in 16 patients. Median age was similar between groups with normal and abnormal blood counts and TBNK subsets.

Lymphopenia but not neutropenia correlated with infections. Using decision tree analysis, absolute lymphocyte counts (ALC) <1.1 and <0.96 cell/µL segregated patients with worse overall survival (OS) and at increased risk of infections, respectively. CD3 lymphopenia (both CD4 and CD8) correlated with infections requiring hospitalization and opportunistic infections, both of which also associated with poorer OS. B lymphopenia only correlated with recurrent infections and did not impact OS.

Potential underlying mechanisms associated with T lymphopenia in TBDs are increased cell apoptosis due to excessive telomere shortening and an accelerated aged hematopoiesis characterized by decreased T CD4/CD8 ratio and myeloid bias of hematopoietic stem and progenitor cells (HSPC). Telomere length (TL) of T cells was similarly shortened across the entire cohort in comparison to age-matched controls, regardless of ALC and TBNK levels. TBNK immunophenotyping showed that 38/55 (69%) had a decreased CD4/CD8 ratio, a finding further validated in 6 patients by single-cell proteogenomics (scDNA) of peripheral immune subsets. In comparison to young (n=1) and older (n=1) controls, TBD patients had decreased naïve T CD4+ and CD8+ subsets, and accumulation of effector and memory cells, consistent with an aged immune system. Increased frequencies of naïve T, NK and B cells were observed in 2/6 patients, both with PPM1D or TERTp somatic mutations.

In the entire cohort, clonal hematopoiesis (CH) in MDS-related genes (particularly in U2AF1S34 and TP53 but not PPM1D) associated with low ALC and CD3/4/8 levels (p < 0.05). scRNA-seq of HSCs from patients with germline TERT/TERC (n=2) without CH showed the lymphoid and myeloid progenitor pool (LMPP) intrinsically biased towards myeloid differentiation, with increased expression of myeloid markers in comparison to LMPP from age-matched controls. Although MDS-related mutations are known to be associated with a myeloid biased hematopoiesis, differential expression of U2AF1S34 vs. U2AF1wild-type LMPP by scRNA-seq were equivalent.

In conclusion, immunodeficiency in adult TBDs is characterized by T lymphopenia and likely consequent to accelerated aged hematopoiesis. Low ALC and T CD3/4/8 levels may be useful as biomarkers of increased risk of clinically significant infections and poor OS.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH